Tenax Therapeutics (TENX) Competitors $5.83 +0.06 (+1.11%) Closing price 03:58 PM EasternExtended Trading$5.82 -0.01 (-0.22%) As of 07:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TENX vs. HURA, IOBT, WHWK, OCX, VIRI, CRBP, ADAG, ENTX, ORMP, and JMACShould you be buying Tenax Therapeutics stock or one of its competitors? The main competitors of Tenax Therapeutics include TuHURA Biosciences (HURA), IO Biotech (IOBT), Whitehawk Therapeutics (WHWK), OncoCyte (OCX), Virios Therapeutics (VIRI), Corbus Pharmaceuticals (CRBP), Adagene (ADAG), Entera Bio (ENTX), Oramed Pharmaceuticals (ORMP), and Maxpro Capital Acquisition (JMAC). These companies are all part of the "pharmaceutical products" industry. Tenax Therapeutics vs. Its Competitors TuHURA Biosciences IO Biotech Whitehawk Therapeutics OncoCyte Virios Therapeutics Corbus Pharmaceuticals Adagene Entera Bio Oramed Pharmaceuticals Maxpro Capital Acquisition TuHURA Biosciences (NASDAQ:HURA) and Tenax Therapeutics (NASDAQ:TENX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, earnings, profitability, valuation, dividends and institutional ownership. Does the media prefer HURA or TENX? In the previous week, TuHURA Biosciences and TuHURA Biosciences both had 1 articles in the media. Tenax Therapeutics' average media sentiment score of 1.89 beat TuHURA Biosciences' score of 0.44 indicating that Tenax Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment TuHURA Biosciences Neutral Tenax Therapeutics Very Positive Which has better earnings & valuation, HURA or TENX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTuHURA BiosciencesN/AN/A-$21.68MN/AN/ATenax TherapeuticsN/AN/A-$17.60M-$2.48-2.35 Which has more volatility and risk, HURA or TENX? TuHURA Biosciences has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Comparatively, Tenax Therapeutics has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Is HURA or TENX more profitable? TuHURA Biosciences' return on equity of 291.69% beat Tenax Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets TuHURA BiosciencesN/A 291.69% 122.09% Tenax Therapeutics N/A -31.51%-30.35% Do analysts recommend HURA or TENX? TuHURA Biosciences currently has a consensus price target of $12.67, suggesting a potential upside of 450.72%. Tenax Therapeutics has a consensus price target of $17.50, suggesting a potential upside of 199.97%. Given TuHURA Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe TuHURA Biosciences is more favorable than Tenax Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.40Tenax Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25 Do insiders & institutionals hold more shares of HURA or TENX? 0.6% of TuHURA Biosciences shares are owned by institutional investors. Comparatively, 1.7% of Tenax Therapeutics shares are owned by institutional investors. 0.2% of TuHURA Biosciences shares are owned by insiders. Comparatively, 3.1% of Tenax Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryTuHURA Biosciences and Tenax Therapeutics tied by winning 5 of the 10 factors compared between the two stocks. Get Tenax Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TENX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TENX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TENX vs. The Competition Export to ExcelMetricTenax TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$23.95M$2.99B$5.61B$9.11BDividend YieldN/A2.39%5.24%4.01%P/E Ratio-2.357.5819.7619.92Price / SalesN/A292.00430.8999.65Price / CashN/A42.8637.4658.16Price / Book0.227.638.045.49Net Income-$17.60M-$55.05M$3.18B$250.27M7 Day Performance-2.11%8.54%3.72%4.78%1 Month Performance1.11%5.38%3.72%7.20%1 Year Performance71.59%2.35%29.92%17.27% Tenax Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TENXTenax Therapeutics1.7588 of 5 stars$5.83+1.1%$17.50+200.0%+75.5%$23.95MN/A-2.359Positive NewsGap UpHURATuHURA Biosciences1.3946 of 5 stars$2.23+0.5%$12.67+468.0%N/A$96.97MN/A0.00N/AIOBTIO Biotech3.694 of 5 stars$1.39-3.5%$9.33+571.5%+12.9%$94.87MN/A-0.9330News CoverageWHWKWhitehawk TherapeuticsN/A$1.87-3.1%N/AN/A$90.92M$25.98M0.0040Positive NewsOCXOncoCyte2.071 of 5 stars$3.18+16.3%$6.06+90.9%+5.1%$90.80M$3.84M-0.90120VIRIVirios TherapeuticsN/A$4.71-1.3%$5.00+6.2%+1,814.4%$90.71MN/A-17.445CRBPCorbus Pharmaceuticals4.465 of 5 stars$6.90-6.8%$50.88+637.3%-83.8%$90.55MN/A-1.6440Positive NewsADAGAdagene2.6513 of 5 stars$1.95+1.6%$8.00+310.3%-29.7%$90.45M$100K0.00260ENTXEntera Bio2.7938 of 5 stars$1.90-4.0%$10.00+426.3%+1.9%$89.99M$180K-7.3120ORMPOramed Pharmaceuticals1.0468 of 5 stars$2.25+4.7%N/A-14.9%$87.83M$1.34M-5.1110JMACMaxpro Capital AcquisitionN/A$6.51+1.5%N/A+3,250.7%$87.42MN/A0.002,021News CoverageGap Up Related Companies and Tools Related Companies TuHURA Biosciences Alternatives IO Biotech Alternatives Whitehawk Therapeutics Alternatives OncoCyte Alternatives Virios Therapeutics Alternatives Corbus Pharmaceuticals Alternatives Adagene Alternatives Entera Bio Alternatives Oramed Pharmaceuticals Alternatives Maxpro Capital Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TENX) was last updated on 7/11/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tenax Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tenax Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
